A novel L-3-hydroxyacyl-CoA dehydrogenase from human brain has been cloned, expressed, purified, and characterized. This enzyme is a homotetramer with a molecular mass of 108 kDa. Its subunit consists of 261 amino acid residues and has structural features characteristic of short chain dehydrogenases. It was found that the amino acid sequence of this human brain enzyme is identical to that of an endoplasmic reticulum amyloid -peptide-binding protein (ERAB), which mediates neurotoxicity in Alzheimer's disease (Yan, S. D., Fu, J., Soto, C., Chen, X., Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A., Stern, E., Saido, T., Tohyama, M., Ogawa, S., Roher, A., and Stern, D. (1997) Nature 389, 689 -695). The purification of human brain short chain L-3-hydroxyacyl-CoA dehydrogenase made it possible to characterize the structural and catalytic properties of ERAB. This NAD ؉ -dependent dehydrogenase catalyzes the reversible oxidation of L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the D-isomers. The catalytic rate constant of the purified enzyme was estimated to be 37 s ؊1 with apparent K m values of 89 and 20 M for acetoacetyl-CoA and NADH, respectively. The activity ratio of this enzyme for substrates with chain lengths of C 4 , C 8 , and C 16 was ϳ1:2:2. The human short chain L-3-hydroxyacyl-CoA dehydrogenase gene is organized into six exons and five introns and maps to chromosome Xp11.2. The amino-terminal NAD-binding region of the dehydrogenase is encoded by the first three exons, whereas the other exons code for the carboxyl-terminal substratebinding region harboring putative catalytic residues. The results of this study lead to the conclusion that ERAB involved in neuronal dysfunction is encoded by the human short chain L-3-hydroxyacyl-CoA dehydrogenase gene.L-3-Hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35) catalyzes the third step of the fatty acid -oxidation pathway: L-3-hydroxyacyl-CoA ϩ NAD ϩ i 3-ketoacyl-CoA ϩ NADH ϩ H ϩ (1). This reaction is known to be catalyzed by mitochondrial monofunctional L-3-hydroxyacyl-CoA dehydrogenase and by prokaryotic and eukaryotic multifunctional -oxidation enzymes that possess an L-3-hydroxyacyl-CoA dehydrogenase functional domain (2, 3). The catalytic residue of this kind of dehydrogenase was recently identified to be a conserved histidine (4), and a conserved glutamate residue is also required for high catalytic efficiency (5). The catalytic residue of L-3-hydroxyacyl-CoA dehydrogenase was proposed to interact with the conserved glutamate, and this electrostatic interaction seemed to be strengthened by the binding of substrate (5). However, we were surprised to see that a catalytic His-Glu pair is not present in the newly isolated bovine liver type II dehydrogenase (6, 7), which is not homologous to any of the known L-3-hydroxyacylCoA dehydrogenases. More interestingly, it was reported that this new type of L-3-hydroxyacyl-CoA dehydrogenase was not found in human liver by either Northern blot or immunoblot analysis (6, 7). As a result, several important q...